참고문헌
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 2022;75:524. https://doi.org/10.1016/j.rec.2022.05.006
- Writing Committee Members; Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:450-500. https://doi.org/10.1016/j.jacc.2020.11.035
- Korteland NM, Top D, Borsboom GJ, Roos-Hesselink JW, Bogers AJ, Takkenberg JJ. Quality of life and prosthetic aortic valve selection in non-elderly adult patients. Interact Cardiovasc Thorac Surg 2016;22:723-8. https://doi.org/10.1093/icvts/ivw021
- Tasoudis PT, Varvoglis DN, Vitkos E, et al. Mechanical versus bioprosthetic valve for aortic valve replacement: systematic review and meta-analysis of reconstructed individual participant data. Eur J Cardiothorac Surg 2022;62:ezac268. https://doi.org/10.1093/ejcts/ezac268
- Lu R, Dismorr M, Glaser N, Sartipy U. Aortic valve replacement with mechanical valves vs perimount bioprostheses in 50-to 69-year-old patients. JACC Adv 2023;2:100359. https://doi.org/10.1016/j.jacadv.2023.100359
- Song Y, Kim KT, Park SJ, et al. Mechanical versus bioprosthetic aortic valve replacement in patients aged 50 to 70 years. J Chest Surg 2024;57:241-51. https://doi.org/10.5090/jcs.23.143
- Tam DY, Dharma C, Rocha RV, et al. Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis: early and late outcomes in a propensity-matched cohort. JACC Cardiovasc Interv 2020;13:765-74. https://doi.org/10.1016/j.jcin.2019.10.030
- Fath AR, Aglan A, Eldaly A, Olagunju A, Almomani A. Long-term outcomes for contemporary mechanical versus bioprosthetic surgical mitral valve replacement in patients aged 50 to 70 years. Circulation 2023;148(Suppl_1):A14162. https://doi.org/10.1161/circ.148.suppl_1.14162
- Alkhouli M, Alqahtani F, Kawsara A, Pislaru S, Schaff HV, Nishimura RA. National trends in mechanical valve replacement in patients aged 50 to 70 years. J Am Coll Cardiol 2020;76:2687-8. https://doi.org/10.1016/j.jacc.2020.09.608
- Zhao W, Chen Z, Chen S, et al. Long-term outcomes of bioprosthetic and mechanical valve replacement for patients aged between 50 and 70 years. Rev Cardiovasc Med 2023;24:253. https://doi.org/10.31083/j.rcm2409253